Biologic treatments for elderly patients with psoriasis

The Safety of Anti-TNF Agents in the Elderly

(2017) A. Migliore et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

(2015) K. Kubota et al.   BMJ Open

Hepatitis B virus reactivation after ustekinumab treatment: reply from authors

(2013) T.-F. Tsai   BRITISH JOURNAL OF DERMATOLOGY

Ustekinumab Associated With Flares of Psoriatic Arthritis

(2013) Emily F. Stamell et al.   JAMA Dermatology

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

(2012) T.-F. Tsai et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

(2011) J. Barker et al.   BRITISH JOURNAL OF DERMATOLOGY

Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients

(2010) AI Sánchez-Moya et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients

(2009) M. D. Koller et al.   RHEUMATOLOGY

Reduced Elimination of Cyclosporine A in Elderly (>65 Years) Kidney Transplant Recipients

(2008) Pål Falck et al.   TRANSPLANTATION